Report Detail

Request for Sample of this report

Other Global CRISPR Genome Editing Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4711518
    • |
  • 17 June, 2026
    • |
  • Global
    • |
  • 119 Pages
    • |
  • GIR
    • |
  • Other

According to our (Global Info Research) latest study, the global CRISPR Genome Editing market size was valued at US$ 467 million in 2025 and is forecast to a readjusted size of US$ 655 million by 2032 with a CAGR of 5.0% during review period.
CRISPR Genome Editing tools are molecular systems derived from bacterial immune mechanisms that allow scientists to precisely cut, modify, or regulate DNA within living cells. The core components include the Cas nuclease (such as Cas9 or Cas12) and a guide RNA that directs the nuclease to a specific DNA sequence, enabling targeted gene knockouts, insertions, corrections, or modulation of gene expression. These tools have reshaped biotechnology by offering high accuracy, programmability, and relative simplicity compared with earlier gene-editing methods. They are widely used in basic research, agriculture, drug discovery, and emerging therapeutic applications aimed at treating genetic diseases.
CRISPR Genome Editing sits within a value chain that begins upstream with the development of core biological components—Cas enzymes (Cas9, Cas12, Cas13), guide RNA synthesis, delivery systems (viral vectors, lipid nanoparticles, RNP complexes), and specialized laboratory tools such as sequencing platforms, reagents, and cell-culture systems. These inputs feed into technology providers and research institutions that design, optimize, and validate CRISPR constructs, therapeutic pipelines, and agricultural or industrial applications. Downstream, CRISPR-enabled products and services flow into biotechnology and pharmaceutical companies developing gene therapies, diagnostics, and engineered cell lines; agricultural firms creating improved crops; and industrial or academic labs using CRISPR for basic research. Regulatory agencies, clinical trial service providers, and intellectual-property licensors form the final part of the chain. In short, CRISPR Genome Editing relies on an upstream supply of enzymes, guide RNAs, and delivery technologies, and serves downstream markets in therapeutics, diagnostics, agriculture, and scientific research.
CRISPR Genome Editing is moving from a high-growth research technology toward a diversified commercial market driven first by therapeutic pipelines and secondarily by diagnostics and agriculture. Clinical progress—an increasing number of CRISPR, base-editing and prime-editing trials (ex vivo and in vivo) is driving near-term value creation as companies advance toward pivotal data and potential approvals. Strategic partnerships, licensing deals and selective M&A (including large pharma buying early-stage gene-editing assets) are re-shaping capital flows and derisking programs for big-pharma commercialization. However, the market’s pace and addressable value depend heavily on solving delivery, safety and regulatory hurdles—efficient, tissue-specific delivery (LNPs, AAVs and next-gen vectors), off-target risk reduction, and clear regulatory pathways remain critical technical and adoption barriers. Finally, non-therapeutic applications (crop improvement, livestock traits, industrial biotech, and rapid CRISPR-based diagnostics) represent sizable adjacent markets that both diversify revenue streams and raise regionally divergent regulatory and public-acceptance questions that investors and developers must manage.
This report is a detailed and comprehensive analysis for global CRISPR Genome Editing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Tool Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global CRISPR Genome Editing market size and forecasts, in consumption value ($ Million), 2021-2032
Global CRISPR Genome Editing market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global CRISPR Genome Editing market size and forecasts, by Tool Type and by Application, in consumption value ($ Million), 2021-2032
Global CRISPR Genome Editing market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for CRISPR Genome Editing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global CRISPR Genome Editing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Merck KGaA, Integrated DNA Technologies (IDT), Takara Bio, New England Biolabs, GenScript, Aldevron, TriLink Biotechnologies, Synthego, KACTUS Bio, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
CRISPR Genome Editing market is split by Tool Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Tool Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Tool Type
DNA-Cutting Tools
DNA-Editing Without Double-Strand Breaks
RNA Editing Tools
Others
Market segment by Grade
Research Grade
GMP Grade
Market segment by Product Type
CRISPR-Cas9
CRISPR-Cas12a (Cpf1)
Base Editors (CBE & ABE)
Others
Market segment by Application
Agricultural
Biomedical
Industrial
Others
Market segment by players, this report covers
Thermo Fisher Scientific
Merck KGaA
Integrated DNA Technologies (IDT)
Takara Bio
New England Biolabs
GenScript
Aldevron
TriLink Biotechnologies
Synthego
KACTUS Bio
Fortis Life Sciences
Shandong Shunfeng Biotechnology
Renman Biotechnology
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe CRISPR Genome Editing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of CRISPR Genome Editing, with revenue, gross margin, and global market share of CRISPR Genome Editing from 2021 to 2026.
Chapter 3, the CRISPR Genome Editing competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Tool Type and by Application, with consumption value and growth rate by Tool Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and CRISPR Genome Editing market forecast, by regions, by Tool Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of CRISPR Genome Editing.
Chapter 13, to describe CRISPR Genome Editing research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of CRISPR Genome Editing by Tool Type
    • 1.3.1 Overview: Global CRISPR Genome Editing Market Size by Tool Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global CRISPR Genome Editing Consumption Value Market Share by Tool Type in 2025
    • 1.3.3 DNA-Cutting Tools
    • 1.3.4 DNA-Editing Without Double-Strand Breaks
    • 1.3.5 RNA Editing Tools
    • 1.3.6 Others
  • 1.4 Classification of CRISPR Genome Editing by Grade
    • 1.4.1 Overview: Global CRISPR Genome Editing Market Size by Grade: 2021 Versus 2025 Versus 2032
    • 1.4.2 Global CRISPR Genome Editing Consumption Value Market Share by Grade in 2025
    • 1.4.3 Research Grade
    • 1.4.4 GMP Grade
  • 1.5 Classification of CRISPR Genome Editing by Product Type
    • 1.5.1 Overview: Global CRISPR Genome Editing Market Size by Product Type: 2021 Versus 2025 Versus 2032
    • 1.5.2 Global CRISPR Genome Editing Consumption Value Market Share by Product Type in 2025
    • 1.5.3 CRISPR-Cas9
    • 1.5.4 CRISPR-Cas12a (Cpf1)
    • 1.5.5 Base Editors (CBE & ABE)
    • 1.5.6 Others
  • 1.6 Global CRISPR Genome Editing Market by Application
    • 1.6.1 Overview: Global CRISPR Genome Editing Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.6.2 Agricultural
    • 1.6.3 Biomedical
    • 1.6.4 Industrial
    • 1.6.5 Others
  • 1.7 Global CRISPR Genome Editing Market Size & Forecast
  • 1.8 Global CRISPR Genome Editing Market Size and Forecast by Region
    • 1.8.1 Global CRISPR Genome Editing Market Size by Region: 2021 VS 2025 VS 2032
    • 1.8.2 Global CRISPR Genome Editing Market Size by Region, (2021-2032)
    • 1.8.3 North America CRISPR Genome Editing Market Size and Prospect (2021-2032)
    • 1.8.4 Europe CRISPR Genome Editing Market Size and Prospect (2021-2032)
    • 1.8.5 Asia-Pacific CRISPR Genome Editing Market Size and Prospect (2021-2032)
    • 1.8.6 South America CRISPR Genome Editing Market Size and Prospect (2021-2032)
    • 1.8.7 Middle East & Africa CRISPR Genome Editing Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Thermo Fisher Scientific
    • 2.1.1 Thermo Fisher Scientific Details
    • 2.1.2 Thermo Fisher Scientific Major Business
    • 2.1.3 Thermo Fisher Scientific CRISPR Genome Editing Product and Solutions
    • 2.1.4 Thermo Fisher Scientific CRISPR Genome Editing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.2 Merck KGaA
    • 2.2.1 Merck KGaA Details
    • 2.2.2 Merck KGaA Major Business
    • 2.2.3 Merck KGaA CRISPR Genome Editing Product and Solutions
    • 2.2.4 Merck KGaA CRISPR Genome Editing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Merck KGaA Recent Developments and Future Plans
  • 2.3 Integrated DNA Technologies (IDT)
    • 2.3.1 Integrated DNA Technologies (IDT) Details
    • 2.3.2 Integrated DNA Technologies (IDT) Major Business
    • 2.3.3 Integrated DNA Technologies (IDT) CRISPR Genome Editing Product and Solutions
    • 2.3.4 Integrated DNA Technologies (IDT) CRISPR Genome Editing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Integrated DNA Technologies (IDT) Recent Developments and Future Plans
  • 2.4 Takara Bio
    • 2.4.1 Takara Bio Details
    • 2.4.2 Takara Bio Major Business
    • 2.4.3 Takara Bio CRISPR Genome Editing Product and Solutions
    • 2.4.4 Takara Bio CRISPR Genome Editing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Takara Bio Recent Developments and Future Plans
  • 2.5 New England Biolabs
    • 2.5.1 New England Biolabs Details
    • 2.5.2 New England Biolabs Major Business
    • 2.5.3 New England Biolabs CRISPR Genome Editing Product and Solutions
    • 2.5.4 New England Biolabs CRISPR Genome Editing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 New England Biolabs Recent Developments and Future Plans
  • 2.6 GenScript
    • 2.6.1 GenScript Details
    • 2.6.2 GenScript Major Business
    • 2.6.3 GenScript CRISPR Genome Editing Product and Solutions
    • 2.6.4 GenScript CRISPR Genome Editing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 GenScript Recent Developments and Future Plans
  • 2.7 Aldevron
    • 2.7.1 Aldevron Details
    • 2.7.2 Aldevron Major Business
    • 2.7.3 Aldevron CRISPR Genome Editing Product and Solutions
    • 2.7.4 Aldevron CRISPR Genome Editing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Aldevron Recent Developments and Future Plans
  • 2.8 TriLink Biotechnologies
    • 2.8.1 TriLink Biotechnologies Details
    • 2.8.2 TriLink Biotechnologies Major Business
    • 2.8.3 TriLink Biotechnologies CRISPR Genome Editing Product and Solutions
    • 2.8.4 TriLink Biotechnologies CRISPR Genome Editing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 TriLink Biotechnologies Recent Developments and Future Plans
  • 2.9 Synthego
    • 2.9.1 Synthego Details
    • 2.9.2 Synthego Major Business
    • 2.9.3 Synthego CRISPR Genome Editing Product and Solutions
    • 2.9.4 Synthego CRISPR Genome Editing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Synthego Recent Developments and Future Plans
  • 2.10 KACTUS Bio
    • 2.10.1 KACTUS Bio Details
    • 2.10.2 KACTUS Bio Major Business
    • 2.10.3 KACTUS Bio CRISPR Genome Editing Product and Solutions
    • 2.10.4 KACTUS Bio CRISPR Genome Editing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 KACTUS Bio Recent Developments and Future Plans
  • 2.11 Fortis Life Sciences
    • 2.11.1 Fortis Life Sciences Details
    • 2.11.2 Fortis Life Sciences Major Business
    • 2.11.3 Fortis Life Sciences CRISPR Genome Editing Product and Solutions
    • 2.11.4 Fortis Life Sciences CRISPR Genome Editing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Fortis Life Sciences Recent Developments and Future Plans
  • 2.12 Shandong Shunfeng Biotechnology
    • 2.12.1 Shandong Shunfeng Biotechnology Details
    • 2.12.2 Shandong Shunfeng Biotechnology Major Business
    • 2.12.3 Shandong Shunfeng Biotechnology CRISPR Genome Editing Product and Solutions
    • 2.12.4 Shandong Shunfeng Biotechnology CRISPR Genome Editing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Shandong Shunfeng Biotechnology Recent Developments and Future Plans
  • 2.13 Renman Biotechnology
    • 2.13.1 Renman Biotechnology Details
    • 2.13.2 Renman Biotechnology Major Business
    • 2.13.3 Renman Biotechnology CRISPR Genome Editing Product and Solutions
    • 2.13.4 Renman Biotechnology CRISPR Genome Editing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Renman Biotechnology Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global CRISPR Genome Editing Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of CRISPR Genome Editing by Company Revenue
    • 3.2.2 Top 3 CRISPR Genome Editing Players Market Share in 2025
    • 3.2.3 Top 6 CRISPR Genome Editing Players Market Share in 2025
  • 3.3 CRISPR Genome Editing Market: Overall Company Footprint Analysis
    • 3.3.1 CRISPR Genome Editing Market: Region Footprint
    • 3.3.2 CRISPR Genome Editing Market: Company Product Type Footprint
    • 3.3.3 CRISPR Genome Editing Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Tool Type

  • 4.1 Global CRISPR Genome Editing Consumption Value and Market Share by Tool Type (2021-2026)
  • 4.2 Global CRISPR Genome Editing Market Forecast by Tool Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global CRISPR Genome Editing Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global CRISPR Genome Editing Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America CRISPR Genome Editing Consumption Value by Tool Type (2021-2032)
  • 6.2 North America CRISPR Genome Editing Market Size by Application (2021-2032)
  • 6.3 North America CRISPR Genome Editing Market Size by Country
    • 6.3.1 North America CRISPR Genome Editing Consumption Value by Country (2021-2032)
    • 6.3.2 United States CRISPR Genome Editing Market Size and Forecast (2021-2032)
    • 6.3.3 Canada CRISPR Genome Editing Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico CRISPR Genome Editing Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe CRISPR Genome Editing Consumption Value by Tool Type (2021-2032)
  • 7.2 Europe CRISPR Genome Editing Consumption Value by Application (2021-2032)
  • 7.3 Europe CRISPR Genome Editing Market Size by Country
    • 7.3.1 Europe CRISPR Genome Editing Consumption Value by Country (2021-2032)
    • 7.3.2 Germany CRISPR Genome Editing Market Size and Forecast (2021-2032)
    • 7.3.3 France CRISPR Genome Editing Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom CRISPR Genome Editing Market Size and Forecast (2021-2032)
    • 7.3.5 Russia CRISPR Genome Editing Market Size and Forecast (2021-2032)
    • 7.3.6 Italy CRISPR Genome Editing Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific CRISPR Genome Editing Consumption Value by Tool Type (2021-2032)
  • 8.2 Asia-Pacific CRISPR Genome Editing Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific CRISPR Genome Editing Market Size by Region
    • 8.3.1 Asia-Pacific CRISPR Genome Editing Consumption Value by Region (2021-2032)
    • 8.3.2 China CRISPR Genome Editing Market Size and Forecast (2021-2032)
    • 8.3.3 Japan CRISPR Genome Editing Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea CRISPR Genome Editing Market Size and Forecast (2021-2032)
    • 8.3.5 India CRISPR Genome Editing Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia CRISPR Genome Editing Market Size and Forecast (2021-2032)
    • 8.3.7 Australia CRISPR Genome Editing Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America CRISPR Genome Editing Consumption Value by Tool Type (2021-2032)
  • 9.2 South America CRISPR Genome Editing Consumption Value by Application (2021-2032)
  • 9.3 South America CRISPR Genome Editing Market Size by Country
    • 9.3.1 South America CRISPR Genome Editing Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil CRISPR Genome Editing Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina CRISPR Genome Editing Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa CRISPR Genome Editing Consumption Value by Tool Type (2021-2032)
  • 10.2 Middle East & Africa CRISPR Genome Editing Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa CRISPR Genome Editing Market Size by Country
    • 10.3.1 Middle East & Africa CRISPR Genome Editing Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey CRISPR Genome Editing Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia CRISPR Genome Editing Market Size and Forecast (2021-2032)
    • 10.3.4 UAE CRISPR Genome Editing Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 CRISPR Genome Editing Market Drivers
  • 11.2 CRISPR Genome Editing Market Restraints
  • 11.3 CRISPR Genome Editing Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 CRISPR Genome Editing Industry Chain
  • 12.2 CRISPR Genome Editing Upstream Analysis
  • 12.3 CRISPR Genome Editing Midstream Analysis
  • 12.4 CRISPR Genome Editing Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on CRISPR Genome Editing. Industry analysis & Market Report on CRISPR Genome Editing is a syndicated market report, published as Global CRISPR Genome Editing Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of CRISPR Genome Editing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo